In contrast, most (6/8) male mice treated with the combination of anti-IL-1α plus anti-IL-1β antibodies (anti-IL-1α/β) developed orofacial abscesses beginning 5–7 days after infection, pathognomonic for disseminating dentoalveolar infections (Figure 1a). Here, IL1B is linked to infection.